PRESS STATEMENTS05.11.2021 Pfizer’s Novel Prediction Model, Derived from Machine Learning, Shows Robust Performance for Identifying Heart Failure Patients At-Risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, a Rare and Life-Threatening Condition Associated with Progressive H05.04.2021 Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling05.04.2021 Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate04.22.2021 Pfizer Announces 2021 Shareholder Meeting Results04.09.2021 Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents03.03.2021 Pfizer-BioNTech’s COVID-19 Vaccine Arrives in Rwanda02.25.2021 Pfizer Statement on Results of Second Annual Pay Equity Study Among Colleagues Worldwide02.19.2021 President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility02.17.2021 In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations02.08.2021 Pfizer and BioNTech Publish Data from in Vitro Studies in "Nature Medicine" Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants02.01.2021 Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature01.29.2021 Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science01.27.2021 In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants01.26.2021 Statement on ATMI Ranking01.20.2021 Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture01.15.2021 Statement by Pfizer Chairman and CEO Albert Bourla01.15.2021 Statement on European Upscaling as well as Impact on Deliveries01.08.2021 An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission12.17.2020 Pfizer Update on COVID-19 Vaccine Distribution12.15.2020 Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development ProgramPagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesOur PurposeDoing Better: Increasing Diversity in Clinical TrialsOur PurposePartnering to RETHINK Vaccine Confidence and RE:SET Mental…Our PurposeImproving Metastatic Breast Cancer Care for Underserved…Our ScienceAn Open Letter from Pfizer Chairman and CEO to ColleaguesOur PurposeReimagining Primary Healthcare in Bogor, IndonesiaOur PurposeSupporting India in Its Time of NeedOur PeopleMeet Dacia Young, a Senior Scientist within the Vaccine Research…Our PurposeWisconsin is Ready for CuresYour HealthIn His Shoes (or Hiking Boots): William’s epic solo adventure to…Our PurposeMichigan is Ready for CuresYour HealthUnderstanding Healthcare Disparities in Colorectal CancerYour HealthKnow the Mutational Status of Your Cancer: Biomarker Testing in…Your HealthPfizer's New C. difficile Awareness Initiative ExplainedYour HealthAlbert Bourla Reflects on the One Year Anniversary of the COVID-…Our PeopleGetting to Know Pfizer’s New Chief Medical Officer Aida HabtezionOur PurposeSome older people living with cancer aim for remission but lack…How To Make Successful Health ResolutionsRheumatoid Arthritis: Pregnancy And MotherhoodHealth Questions to Ask Your MotherReboot Your BodySmoking – A Potentially Deadly SecretShowHide
